CM
AMED

Capula Management’s Amedisys AMED Stock Holding History

Capula Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,244
Closed -$206K – 492
2024
Q2 		$206K Sell
2,244
-2,312
-51% -$215K ﹤0.01% 392
2024
Q1 		$420K Buy
+4,556
New +$427K 0.01% 259
2021
Q4 		– Sell
-2,876
Closed -$429K – 210
2021
Q3 		$429K Buy
+2,876
New +$598K 0.01% 631

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capula Management's AMED Position: Q3 2024 in Review

Capula Management sold out of Amedisys (AMED) in Q3 2024, closing a stake of 2,244 shares — an estimated $206K sold.

Capula Management first reported a position in AMED in Q3 2021 and held it in 3 quarters. The position peaked at $429K in Q3 2021. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Capula Management reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Capula Management sold 2,244 Amedisys shares in Q3 2024, an estimated $206K.
  • Capula Management first reported a position in Amedisys in Q3 2021 and held it in 3 quarters.
  • Capula Management's Amedisys position peaked at $429K in Q3 2021.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Capula Management's 13F filing for Q3 2024, filed 13 Nov 2024.